Tag: Alkermes

Alkermes to acquire Boston-based neuroscience company Rodin Therapeutics

pharmanewsdaily- November 19, 2019

Alkermes acquisition of Rodin Therapeutics : Irish biopharma company Alkermes has agreed to acquire Boston-based neuroscience company Rodin Therapeutics in a deal worth up to ... Read More

Alkermes to evaluate ALKS 4230, pembrolizumab combo for solid tumors

pharmanewsdaily- September 11, 2018

Irish biopharma company Alkermes said that it has expanded an ongoing phase 1 trial for its immuno oncology drug ALKS 4230 to assess its safety ... Read More